Reports for GLENMARK PHARMACEUTICALS CANADA INC.

Company Name

GLENMARK PHARMACEUTICALS CANADA INC.

Totals

Shortage reports

21

Actual shortage: 4 (19%)
Anticipated shortage: 0 (0%)
Avoided shortage: 0 (0%)
Resolved: 17 (81%)

Discontinuation Reports

0

To be discontinued: 0
Discontinued: 0
Reversed: 0

Late reports

4 (19%)

Overdue reports

3 (75%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
GLN-URSODIOL 500MG TABLET Resolved 2017-11-28 2018-01-02 30989

Showing 21 to 21 of 21

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports

Showing 1 to 0 of 0